Evaluation of Fc-receptor positive (FcR+) and negative (FcR-) monocyte subsets in sepsis

Shock

Volumn 11, Issue 4, 1999, Pages 229-234

  Schinkel, Christian ^a   Sendtner, Raimund ^a   Zimmer, Svenja ^a   Walz, Alfred ^b   Hültner, Lothar ^c   Faist, Eugen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c Institute for Clinical Hematology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HLA DR ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; PREDICTION AND FORECASTING; SEPSIS;

ADULT; AGED; FEMALE; HLA-DR ANTIGENS; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; MONOCYTES; PREDICTIVE VALUE OF TESTS; RECEPTORS, FC; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033111701     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199904000-00001     Document Type: Article

References (28)

1. Alexander JW: The role of host defense mechanisms in surgical infections. Surg Clin North Am 60:107-116, 1980.
2. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA: Sepsis syndrome: A valid clinical entity. Crit Care Med 17:389-399, 1989.
3. Parrillo JE: Pathogenic mechanisms of septic shock. NEJM 328:1471-1477, 1993.
4. Ninnemann JL: Trauma, sepsis, and the immune response. J Burn Care Rehabil 8:462-468, 1987.
5. Baue AE: Multi organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome: Where do we stand? Shock 2:385-397, 1994.
6. Faist E, Schinkel C, Zimmer S: Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 20:454-459, 1996.
7. Wewers MD, Herzyk DJ: Alveolar macrophages differ from blood monocytes in human IL-1 β release: Quantitation by enzyme-linked immunoassays. J Immunol 143:1635-1641, 1989.
8. Zembala M, Uracz W, Ruggiero I, Lemmel EM: Isolation of human monocytes by rosetting with antibody coated human erythrocytes and isopycnic gradient centrifugation. Clin Exp Immunol 49:225-229, 1982.
9. Miller-Graziano CL, Szabo G, Kodys K, Griffey K: Aberrations in post-trauma monocyte (Mφ) subpopulation: Role in septic shock syndrome. J Trauma 30:86-97, 1990.
10. Bone RC, Balk RA, Cerra FB et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655, 1992.
11. Elebute EA, Stoner HB: The grading of sepsis. Br J Surg 70:29-31, 1983.
12. Boyle W: An extension of the 51Cr-release assay for the estimation of mouse cytotoxins. Transplantation 6:761-766, 1968.
13. Rordorf-Adam C, Lazdings J, Woods-Cook K et al: An assay for the detection of interleukin-1 synthesis inhibitors: Effects of antirheumatic drugs. Drugs Exp Clin Res 15:355-362, 1989.
14. Van Snick J, Cayphas S, Vink A et al: Purification and NH2-terminal amino acid sequence of a T-cell derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83:9679-9683, 1986.
15. Mosmann T: Rapid colorometric assay for cellular growth and survival: Application to proliferation and cytotoxic assays. J Immunol Methods 65:55-63, 1983.
16. Peveri P, Walz A, Dewald B, Baggiolini M: A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 167: 1547-1559, 1988.
17. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor TNF from human monocytes. J Immunol Methods 95:99-105, 1986.
18. Faist E, Mewes A, Strasser T et al: Alteration of monocyte function following major injury. Arch Surg 123:287-292, 1988.
19. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr: Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77:204-207, 1990.
20. Hershman MJ, Cheadle WG, George CD, Kuftinex D, Polk HC Jr: An outcome predictive score for sepsis and death following trauma. Injury 19:263-266, 1988.
21. Appel SH, Wellhausen SR, Montgomery R, DeWeese RC, Polk HC: Experimental and clinical significance of endotoxin-dependent HLA-DR expression on monocytes. J Surg Res 47:39-44, 1989.
22. Debets JMH, Kampmeijer R, van der Linden MP, Buurman WA, van der Linden PJ: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 17:489-494, 1989.
23. Marano MA, Fong Y, Moldawer LL et al: Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 170:32-38, 1990.
24. Brugger W, Kreutz M, Andreesen R: Macrophage colony-stimulating factor is required for human monocyte survival and acts as a cofactor for their terminal differentiation to macrophages in vitro. J Leukocyte Biol 49:483-488, 1991.
25. Brugger W, Reinhardt D, Galanos C, Andreesen R: Inhibition of in vitro differentiation of human monocytes by lipopolysaccharides (LPS): Phenotypic and functional analysis. Int Immunol 3:221-227, 1991.
26. Marsh CB, Anderson CL, Lowe MP, Wewers MD: Monocyte IL-8 release is induced by two independent FcR gamma R-mediated pathways. J Immunol 157:2632-2637, 1996.
27. Ohkawa S, Martin LN, Yfukunishi Y, Gormus BJ: Regulatory role of FcR+ and FcR-monocyte subsets in mycobacterium leprae-induced lymphoproliferative response in-vitro. Clin Exp Immunol 67:43-50, 1989.
28. Maier RV: The 'angry' macrophage and its impact on host response mechanisms. In Faist E, Meakins J, Schildberg FW (Eds.): Host defense dysfunction in trauma, shock and sepsis. Heidelberg: Springer Verlag, 1993, pp 191-197.